dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:23:56Z
dc.date.available2014-05-27T11:23:56Z
dc.date.created2014-05-27T11:23:56Z
dc.date.issued2009-07-01
dc.identifierMedicina Cutanea Ibero-Latino-Americana, v. 37, n. 4, p. 159-170, 2009.
dc.identifier0210-5187
dc.identifierhttp://hdl.handle.net/11449/71080
dc.identifier2-s2.0-78649386530
dc.identifier2-s2.0-78649386530.pdf
dc.identifier8789480458377552
dc.description.abstractParacoccidioidomycosis is caused by Paracoccidioides brasiliensis, a dimorphic fungus, prevalent in tropical and subtropical America. It is rare in the United States of America, Canada, Asia and Europe and in these countries it is related to immigrants from endemic areas. Paracoccidioidomycosis associated with immunosuppression runs a course with rapid progression and dissemination of the disease, with many cutaneous lesions. The mortality rate is up to 35% when associated with HIV infection or AIDS. The diagnosis depends on visualization of the agent through direct examination, histopathology, or culture. First choice treatment is done with Amphotericin B deoxycholate. Itraconazole is an option for long term treatment. Sporotrichosis is caused by Sporothrix schenckii, the species of reference. Other species have been considered such as: Sporothrix brasiliensis, S.globosa and S.mexicana and the S.schenckii var. lurei. It is a ubiquitous disease although more prevalent in tropical and subtropical areas. Currently, it has been reported as a zoonotic disease of cats and dogs, with transmission to their owners in the city of Rio de Janeiro (Brazil). Sporotrichosis associated to immunosuppression is uncommon or underreported. There were 34 cases in association with HIV infection or AIDS reported so far. Presenting with disseminated disease and non cutaneous lesions including joints, lungs and central nervous system. Amphotericin B deoxycholate is the first choice for treatment and itraconazol considered an alternative.
dc.languagepor
dc.relationMedicina Cutanea Ibero-Latino-Americana
dc.relation0,126
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAIDS
dc.subjectCorticosteroid therapy
dc.subjectHIV infection
dc.subjectImmunosuppression
dc.subjectParacoccidioidomycosis
dc.subjectRenal transplant
dc.subjectSporotrichosis
dc.subjectamphotericin B deoxycholate
dc.subjectitraconazole
dc.subjectacquired immune deficiency syndrome
dc.subjectAsia
dc.subjectBrazil
dc.subjectCanada
dc.subjectcat
dc.subjectcentral nervous system
dc.subjectdisease association
dc.subjectdisease course
dc.subjectdog
dc.subjectdrug choice
dc.subjectendemic disease
dc.subjectEurope
dc.subjectfungus culture
dc.subjectfungus transmission
dc.subjecthistopathology
dc.subjecthuman
dc.subjectHuman immunodeficiency virus infection
dc.subjectimmigrant
dc.subjectimmune deficiency
dc.subjectlong term care
dc.subjectlung
dc.subjectmortality
dc.subjectnonhuman
dc.subjectParacoccidioides brasiliensis
dc.subjectreview
dc.subjectskin manifestation
dc.subjectSouth American blastomycosis
dc.subjectSporothrix
dc.subjectSporothrix brasiliensis
dc.subjectSporothrix globosa
dc.subjectSporothrix mexicana
dc.subjectSporothrix schenckii
dc.subjectsporotrichosis
dc.subjecttropics
dc.subjectUnited States
dc.subjectzoonosis
dc.titleParacoccidioidomicose é esporotricose associada à imunossupressão
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución